MISSION
Mirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. We are passionate about advancing scientific discoveries to become important medicines for rare disease patients. We are collaborative, creative, and experienced professionals and we’re looking to augment our team with other individuals who embody our values: care, be real, get it done, and have fun, seriously.
POSTION SUMMARY
The Senior Manager/Associate Director Corporate Development will report to the Executive Director of Corporate Development. This position requires an ability to quickly grasp and articulate scientific, clinical, commercial, and strategic topics relevant to the evaluation of potential partnering opportunities in the backdrop of Mirum’s strategic priorities. The individual chosen for this role will:
PRIMARY RESPONSIBILITIES
- Proactively source potential peri-clinical and clinical stage assets using a variety of databases, secondary research sources, by attending partnering conferences, networking, and staying abreast of industry trends and advancements.
- Identify, evaluate, and prioritize new business opportunities, including partnerships, licensing, collaborations, and M&A
- Coordinate team diligence efforts including scientific and clinical reviews and commercial assessments
- Support all aspects of transaction execution, including due diligence, financial modeling, valuation analysis, contract negotiations, and post-deal integration planning.
- Conduct interviews with key opinion leaders as needed to gain insights into new disease areas and new therapies in development.
- Prepare and deliver presentations, deal proposals, and updates to senior leadership and board-level stakeholders.
- Participate in strategic projects to support corporate development initiatives.
- Manage outside consultants as needed to support new opportunity assessments.
- work with the R&D team to assess the technical feasibility and fit of potential of clinical stage assets with existing product pipeline and company capabilities.
QUALIFICATIONS
Education/Experience:
- A PhD, MD, MD/PhD, or Pharm D. with a keen scientific acumen and strong interest and/or experience in biotech/pharma.
- Management consulting background is desirable.
Knowledge, Skills and Abilities:
- Genuine interest in healthcare and patient focused work
- Strong organizational skills, with the ability to prioritize critical workstreams while balancing many projects.
- Strong project management skills with the ability to manage cross-functional teams in evaluating partnering opportunities.
- Highly collaborative with the ability to thrive in a fast-paced, dynamic, and entrepreneurial environment
- Strong communication skills with the ability to effectively communicate scientific and clinical findings in written and oral formats.
- Ability to produce high quality outputs of due diligence findings to enable decision-making.
- Ability to present individual and team recommendations clearly and concisely and foster cross-functional consensus-building.
- Excellent analytical skills, with the ability to synthesize complex scientific and business information.
The salary range for this position is $190,000 to $205,000 USD. Compensation will be determined based on several factors including, but not limited to; skill set, years of experience, and the employee’s geographic location. Please note that the required compensation details listed in US role postings reflect the base salary only, and do not include bonus, equity, or benefits unless otherwise provided.
#LI-HYBRID
Mirum Pharmaceuticals is committed to Equal Employment Opportunity (EEO) and to compliance with all Federal, State and Local laws that prohibit employment discrimination on the basis of race, age, national origin, ethnicity, religion, gender, gender identity, pregnancy, marital status, sexual orientation, citizenship, genetic disposition or characteristics, disability, veteran’s status or any other classification protected by applicable State/Federal/Local laws.
Mirum Pharmaceuticals provides reasonable accommodation for qualified individuals with disabilities and disabled veterans in job application procedures.
What We Do
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. Mirum’s approved medication is LIVMARLI® (maralixibat) oral solution which is approved in the U.S. for the treatment of cholestatic pruritus in patients with Alagille syndrome one year of age and older.
Mirum’s late-stage pipeline includes two investigational treatments for debilitating liver diseases affecting children and adults. Maralixibat (LIVMARLI), an oral ileal bile acid transporter (IBAT) inhibitor, is currently being evaluated in clinical trials for pediatric liver diseases and includes the MARCH Phase 3 study for progressive familial intrahepatic cholestasis (PFIC) and the EMBARK Phase 2b study for patients with biliary atresia. In addition, Mirum has an expanded access program open in Canada, Australia, the UK and several countries in Europe for eligible patients with Alagille syndrome.
Mirum has submitted a Marketing Authorization Application to the European Medicines Agency for maralixibat for the treatment of cholestatic liver disease in patients with Alagille syndrome.
Mirum’s second investigational treatment, volixibat, also an oral IBAT inhibitor, is being evaluated in three potentially registrational studies including the OHANA Phase 2b study for pregnant women with intrahepatic cholestasis of pregnancy, VISTAS Phase 2b study for adults with primary sclerosing cholangitis, and the VANTAGE Phase 2b study for primary biliary cholangitis.
